These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 33446609)

  • 1. Risk factors associated with the development of interstitial lung abnormalities.
    Buendía-Roldán I; Fernandez R; Mejía M; Juarez F; Ramirez-Martinez G; Montes E; Pruneda AKS; Martinez-Espinosa K; Alarcon-Dionet A; Herrera I; Becerril C; Chavez-Galan L; Preciado M; Pardo A; Selman M
    Eur Respir J; 2021 Aug; 58(2):. PubMed ID: 33446609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of hiatus hernia with CT-based interstitial lung changes: the MESA Lung Study.
    Kim JS; Kim J; Yin X; Hiura GT; Anderson MR; Hoffman EA; Raghu G; Noth I; Manichaikul A; Rich SS; Smith BM; Podolanczuk AJ; Garcia CK; Barr RG; Prince MR; Oelsner EC
    Eur Respir J; 2023 Jan; 61(1):. PubMed ID: 35777776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Proteomic Profile of Interstitial Lung Abnormalities.
    Axelsson GT; Gudmundsson G; Pratte KA; Aspelund T; Putman RK; Sanders JL; Gudmundsson EF; Hatabu H; Gudmundsdottir V; Gudjonsson A; Hino T; Hida T; Hobbs BD; Cho MH; Silverman EK; Bowler RP; Launer LJ; Jennings LL; Hunninghake GM; Emilsson V; Gudnason V
    Am J Respir Crit Care Med; 2022 Aug; 206(3):337-346. PubMed ID: 35438610
    [No Abstract]   [Full Text] [Related]  

  • 4. MUC5B promoter polymorphism and interstitial lung abnormalities.
    Hunninghake GM; Hatabu H; Okajima Y; Gao W; Dupuis J; Latourelle JC; Nishino M; Araki T; Zazueta OE; Kurugol S; Ross JC; San José Estépar R; Murphy E; Steele MP; Loyd JE; Schwarz MI; Fingerlin TE; Rosas IO; Washko GR; O'Connor GT; Schwartz DA
    N Engl J Med; 2013 Jun; 368(23):2192-200. PubMed ID: 23692170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentrations of Krebs von den Lungen-6, surfactant protein D, and matrix metalloproteinase-2 as diagnostic biomarkers in patients with asbestosis and silicosis: a case-control study.
    Xue C; Wu N; Li X; Qiu M; Du X; Ye Q
    BMC Pulm Med; 2017 Nov; 17(1):144. PubMed ID: 29149883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study.
    Dressen A; Abbas AR; Cabanski C; Reeder J; Ramalingam TR; Neighbors M; Bhangale TR; Brauer MJ; Hunkapiller J; Reeder J; Mukhyala K; Cuenco K; Tom J; Cowgill A; Vogel J; Forrest WF; Collard HR; Wolters PJ; Kropski JA; Lancaster LH; Blackwell TS; Arron JR; Yaspan BL
    Lancet Respir Med; 2018 Aug; 6(8):603-614. PubMed ID: 29891356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extensive phenotyping of individuals at risk for familial interstitial pneumonia reveals clues to the pathogenesis of interstitial lung disease.
    Kropski JA; Pritchett JM; Zoz DF; Crossno PF; Markin C; Garnett ET; Degryse AL; Mitchell DB; Polosukhin VV; Rickman OB; Choi L; Cheng DS; McConaha ME; Jones BR; Gleaves LA; McMahon FB; Worrell JA; Solus JF; Ware LB; Lee JW; Massion PP; Zaynagetdinov R; White ES; Kurtis JD; Johnson JE; Groshong SD; Lancaster LH; Young LR; Steele MP; Phillips Iii JA; Cogan JD; Loyd JE; Lawson WE; Blackwell TS
    Am J Respir Crit Care Med; 2015 Feb; 191(4):417-26. PubMed ID: 25389906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Matrix Metalloproteinase-7, Respiratory Symptoms, and Mortality in Community-Dwelling Adults. MESA (Multi-Ethnic Study of Atherosclerosis).
    Armstrong HF; Podolanczuk AJ; Barr RG; Oelsner EC; Kawut SM; Hoffman EA; Tracy R; Kaminski N; McClelland RL; Lederer DJ
    Am J Respir Crit Care Med; 2017 Nov; 196(10):1311-1317. PubMed ID: 28570100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower levels of α-Klotho in serum are associated with decreased lung function in individuals with interstitial lung abnormalities.
    Buendia-Roldan I; Machuca N; Mejía M; Maldonado M; Pardo A; Selman M
    Sci Rep; 2019 Jul; 9(1):10801. PubMed ID: 31346213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reticulation Is a Risk Factor of Progressive Subpleural Nonfibrotic Interstitial Lung Abnormalities.
    Zhang Y; Wan H; Richeldi L; Zhu M; Huang Y; Xiong X; Liao J; Zhu W; Mao L; Xu L; Ye D; Chen L; Liu J; Fu L; Li L; Lan L; Li P; Wang L; Tang X; Luo F
    Am J Respir Crit Care Med; 2022 Jul; 206(2):178-185. PubMed ID: 35426779
    [No Abstract]   [Full Text] [Related]  

  • 11. Telomere length and genetic variant associations with interstitial lung disease progression and survival.
    Newton CA; Oldham JM; Ley B; Anand V; Adegunsoye A; Liu G; Batra K; Torrealba J; Kozlitina J; Glazer C; Strek ME; Wolters PJ; Noth I; Garcia CK
    Eur Respir J; 2019 Apr; 53(4):. PubMed ID: 30635297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preexisting radiological interstitial lung abnormalities are a risk factor for severe radiation pneumonitis in patients with small-cell lung cancer after thoracic radiation therapy.
    Li F; Zhou Z; Wu A; Cai Y; Wu H; Chen M; Liang S
    Radiat Oncol; 2018 May; 13(1):82. PubMed ID: 29716649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.
    Juge PA; Lee JS; Ebstein E; Furukawa H; Dobrinskikh E; Gazal S; Kannengiesser C; Ottaviani S; Oka S; Tohma S; Tsuchiya N; Rojas-Serrano J; González-Pérez MI; Mejía M; Buendía-Roldán I; Falfán-Valencia R; Ambrocio-Ortiz E; Manali E; Papiris SA; Karageorgas T; Boumpas D; Antoniou K; van Moorsel CHM; van der Vis J; de Man YA; Grutters JC; Wang Y; Borie R; Wemeau-Stervinou L; Wallaert B; Flipo RM; Nunes H; Valeyre D; Saidenberg-Kermanac'h N; Boissier MC; Marchand-Adam S; Frazier A; Richette P; Allanore Y; Sibilia J; Dromer C; Richez C; Schaeverbeke T; Lioté H; Thabut G; Nathan N; Amselem S; Soubrier M; Cottin V; Clément A; Deane K; Walts AD; Fingerlin T; Fischer A; Ryu JH; Matteson EL; Niewold TB; Assayag D; Gross A; Wolters P; Schwarz MI; Holers M; Solomon JJ; Doyle T; Rosas IO; Blauwendraat C; Nalls MA; Debray MP; Boileau C; Crestani B; Schwartz DA; Dieudé P
    N Engl J Med; 2018 Dec; 379(23):2209-2219. PubMed ID: 30345907
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Kim JS; Manichaikul AW; Hoffman EA; Balte P; Anderson MR; Bernstein EJ; Madahar P; Oelsner EC; Kawut SM; Wysoczanski A; Laine AF; Adegunsoye A; Ma JZ; Taub MA; Mathias RA; Rich SS; Rotter JI; Noth I; Garcia CK; Barr RG; Podolanczuk AJ
    Thorax; 2023 Jun; 78(6):566-573. PubMed ID: 36690926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease.
    Elhai M; Hoffmann-Vold AM; Avouac J; Pezet S; Cauvet A; Leblond A; Fretheim H; Garen T; Kuwana M; Molberg Ø; Allanore Y
    Arthritis Rheumatol; 2019 Jun; 71(6):972-982. PubMed ID: 30624031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interstitial Lung Abnormalities and the Clinical Course in Patients With COPD.
    Lee TS; Jin KN; Lee HW; Yoon SY; Park TY; Heo EY; Kim DK; Chung HS; Lee JK
    Chest; 2021 Jan; 159(1):128-137. PubMed ID: 32805240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive Early Interstitial Lung Abnormalities in Persons at Risk for Familial Pulmonary Fibrosis: A Prospective Cohort Study.
    Salisbury ML; Markin C; Fadely T; Guttentag AR; Humphries SM; Lynch DA; Kropski JA; Blackwell TS
    Am J Respir Crit Care Med; 2024 Dec; 210(12):1441-1452. PubMed ID: 39137317
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis.
    Kumar NP; Moideen K; Nancy A; Viswanathan V; Thiruvengadam K; Sivakumar S; Hissar S; Nair D; Banurekha VV; Kornfeld H; Babu S
    JAMA Netw Open; 2020 Dec; 3(12):e2027754. PubMed ID: 33258908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Metabolic Biomarkers to Identify Interstitial Lung Abnormalities.
    Tan Y; Jia D; Lin Z; Guo B; He B; Lu C; Xiao C; Liu Z; Zhao N; Bian Z; Zhang G; Zhang W; Liu X; Lu A
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27438829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interstitial lung abnormalities: What do we know and how do we manage?
    Liu Q; Zhang H; Han B; Jiang H; Chung KF; Li F
    Expert Rev Respir Med; 2021 Dec; 15(12):1551-1561. PubMed ID: 34689661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.